The United States leads significantly in R&D expenditure within the pharmaceutical manufacturing sector, with a value of $121.62 billion in 2023, reflecting a year-over-year increase of 10.27%. China follows, investing $30.19 billion and showing robust growth with a 17.06% year-over-year rise. Germany's expenditure stands at $7.92 billion with a modest increase of 2.23%. South Korea demonstrates strong growth in its R&D investment, reaching $3.3 billion, up by 12.32%. Hungary shows a remarkable increase of 23.36%, reaching $1.58 billion. Italy and Taiwan also show positive growth, while Portugal, Israel, Mexico, and Norway exhibit negative growth trends.
Future trends to watch in the global pharmaceutical R&D expenditure include:
- Continued dominance and substantial R&D investments by the United States, driving global innovation.
- China's rapid growth trajectory, potentially leading to a more significant share of global R&D expenditure.
- An increase in investments from emerging markets and smaller economies like Hungary and South Korea.
- Potential for rebound and growth in currently declining markets such as Mexico and Portugal.
Top countries in Business Enterprise R&D Expenditure in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 121,620 | 2023 | +8.24% | +10.27% | View data |
| 2 | 2 China | 30,190 | 2023 | +14.5% | +17.06% | View data |
| 3 | 3 Germany | 7,920 | 2023 | +2.74% | +2.23% | View data |
| 4 | 4 South Korea | 3,300 | 2023 | +8.43% | +12.32% | View data |
| 5 | 5 Hungary | 1,580 | 2023 | +21.77% | +23.36% | View data |
| 6 | 6 Italy | 1,290 | 2023 | +3.38% | +7.38% | View data |
| 7 | 7 United Kingdom | 662.34 | 2023 | +0.086% | +0.12% | View data |
| 8 | 8 Taiwan | 652.39 | 2023 | +3.41% | +5.27% | View data |
| 9 | 9 Poland | 349.18 | 2023 | +14.07% | +2.85% | View data |
| 10 | 10 Portugal | 201.48 | 2023 | +2.95% | -0.29% | View data |
